{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:46:15Z","timestamp":1793033175810,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":813,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro (FAPERJ)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.actatropica.2011.02.007","type":"journal-article","created":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T11:34:10Z","timestamp":1302348850000},"page":"87-96","source":"Crossref","is-referenced-by-count":330,"title":["Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World"],"prefix":"10.1016","volume":"118","author":[{"given":"Luiz F.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando O.","family":"Schubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f4nia L.","family":"Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel V.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro C.","family":"Marzochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2011.02.007_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/clinids\/18.3.381","article-title":"Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala","volume":"18","author":"Arana","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0015","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(87)93053-4","article-title":"Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis","volume":"2","author":"Ballou","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0035-9203(86)90236-1","article-title":"Intralesional glucantime in Leishmania braziliensis braziliensis infections","volume":"80","author":"Barrios","year":"1986","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0035","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","first-page":"1225","article-title":"Antimicrobial: antifungal agents","author":"Bennett","year":"2006"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/clinids\/10.3.560","article-title":"Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies","volume":"10","author":"Berman","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0045","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425255.4.9.1209","article-title":"Treatment of leishmaniasis with miltefosine: 2008 status","volume":"4","author":"Berman","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","article-title":"Treatment of cutaneous leishmaniasis in travelers 2009","volume":"16","author":"Blum","year":"2009","journal-title":"J. Travel Med."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travelers","volume":"53","author":"Blum","year":"2004","journal-title":"JAC"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0060","series-title":"Manual de Vigil\u00e2ncia da Leishmaniose Tegumentar Americana","author":"Brasil","year":"2010"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0065","first-page":"202","article-title":"Contact allergy to metals and their salts. 3. Others metals","volume":"43","author":"Cavelier","year":"1995","journal-title":"Derm. Beruf. Umwelt."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0037-86821988000400002","article-title":"American cutaneous leishmaniasis: presentation and problems of patient management","volume":"21","author":"Chulay","year":"1988","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"21","author":"Convit","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0037-86821996000500007","article-title":"Estudo comparativo entre antimoniato de meglumina, isotianato de pentamidina e sulfato de aminosidina, no tratamento de les\u00f5es cut\u00e2neas prim\u00e1rias causadas por Leishmania (Viannia) braziliensis","volume":"29","author":"Correia","year":"1996","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1590\/S0037-86822003000200013","article-title":"\u00d3bito durante tratamento da leishmaniose tegumentar americana com stibogluconato de s\u00f3dio bp 88\u00ae (shandong xinhua)","volume":"36","author":"Costa","year":"2003","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"22","author":"David","year":"2009","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1590\/S0037-86822003000300009","article-title":"Estudo comparativo da efic\u00e1cia de isotionato de pentamidina administrada em tr\u00eas doses durante uma semana e de N-metil-glucamina 20mgSbV\/kg\/dia durante 20 dias para o tratamento da forma cut\u00e2nea da leishmaniose tegumentar americana","volume":"36","author":"De Paula","year":"2003","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0100","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Including Adverse effects","author":"Deeks","year":"2006"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/jac\/dkg195","article-title":"Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis","volume":"51","author":"Delobel","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1590\/S0037-86822000000600004","article-title":"Avalia\u00e7\u00e4o comparativa da efic\u00e1cia e toxicidade do antimoniato de N-metil-glucamina e do estibogluconato de S\u00f3dio BP88\u00a9 no tratamento da leishmaniose cut\u00e2nea localizada","volume":"33","author":"Deps","year":"2000","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0399-077X(05)81436-2","article-title":"Traitement de la l\u00e9sion cutan\u00e9e de la leishmaniose \u00e0 Leishmania braziliensis: \u00e9chec de l\u2019isethionate de pentamidine","volume":"22","author":"Dimier-David","year":"1992","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0120","unstructured":"FDA, 1994. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting E2A (ICH E2A). http:\/\/www.ich.org\/cache\/compo\/276-254-1.html (cited 1994 Oct 27)."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0125","unstructured":"FDA, 1996. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice (GCP) E6 (R1) Version 10. http:\/\/www.ich.org\/LOB\/media\/MEDIA482.pdf (cited June 1996)."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0130","first-page":"201","article-title":"Tratamento da leishmaniose tegumentar americana com inje\u00e7\u00f5es intralesionais de N-metil-glucamina","volume":"65","author":"Gadelha","year":"1990","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/clinids\/18.1.83","article-title":"Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis","volume":"18","author":"Gasser","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004834.pub2","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","volume":"15","author":"Gonz\u00e1les","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2125.1985.tb02615.x","article-title":"Cardiac effects of sodium stibogluconate","volume":"19","author":"Henderson","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1993.tb00149.x","article-title":"Cutaneous leishmaniasis in British troops from Belize","volume":"128","author":"Hepburn","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0460","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0035-9203(93)90298-5","article-title":"Thrombocytopenia complicating sodium stibogluconate therapy for cutaneous leishmaniasis","volume":"87","author":"Hepburn","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0160","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(94)90237-2","article-title":"Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis","volume":"88","author":"Hepburn","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0035-9203(94)90432-4","article-title":"Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis","volume":"88","author":"Hepburn","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0170","first-page":"465","article-title":"Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies","volume":"87","author":"Hepburn","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0175","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendation for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/infdis\/156.1.73","article-title":"Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis","volume":"156","author":"Jones","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0190","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2146\/ajhp060045","article-title":"Adverse-drug- event rates for high-cost and high-use drugs in the intensive care unit","volume":"63","author":"Kane-Gill","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0195","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/archderm.1978.01640200078022","article-title":"Treatment of cutaneous leishmaniasis with antimony sodium gluconate","volume":"114","author":"Koerber","year":"1978","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0200","first-page":"87","article-title":"Tratamento da leishmaniose tegumentar americana pelo antimoniato de N-metil-glucamina: estudo duplo-cego com doses de 14mg\/Kg\/dia e 28mg\/Kg\/dia de antimoniato","volume":"66","author":"Kopke","year":"1991","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0205","first-page":"259","article-title":"Morte ap\u00f3s uso de antimonial pentavalente em leishmaniose tegumentar americana","volume":"68","author":"Kopke","year":"1993","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0210","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4269\/ajtmh.2007.77.640","article-title":"A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis","volume":"77","author":"Krolewiecki","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0215","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-4362.2002.01633.x","article-title":"Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam","volume":"41","author":"Lai","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0220","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0035-9203(83)90185-2","article-title":"The American leishmaniases: some observations on their ecology and epidemiology","volume":"77","author":"Lainson","year":"1983","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.trstmh.2005.03.012","article-title":"Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellers","volume":"100","author":"Lawn","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0230","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0365-05962007000200002","article-title":"Tratamento da leishmaniose tegumentar americana","volume":"82","author":"Lima","year":"2007","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0240","doi-asserted-by":"crossref","unstructured":"Loke, Y.K., Price, D., Herxheimer, A., 2007. Systematic reviews of adverse effects: framework for a structural approach, BMC Med. Res. Methodol. 7, 32. http:\/\/www.biomedcenter.com\/1471-2288\/7\/32 (accessed April 23, 2008).","DOI":"10.1186\/1471-2288-7-32"},{"issue":"326(11)","key":"10.1016\/j.actatropica.2011.02.007_bib0245","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"12","author":"Martinez","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.actatropica.2011.02.007_bib0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","article-title":"Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate","volume":"24","author":"Martinez","year":"1997","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.actatropica.2011.02.007_bib0255","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1590\/S0102-311X1994000800014","article-title":"Tegumentary and visceral leishmaniasis in Brazil: emerging anthropozoonosis and possibilities for their control","volume":"10","author":"Marzochi","year":"1994","journal-title":"Cad. Saude Publica"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00034980120064355","article-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"95","author":"Nacher","year":"2001","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/S0365-05962005000300004","article-title":"Estudo cl\u00ednico, epidemiologico e terap\u00eautico de 402 pacientes com leishmaniose tegumentar americana atendidos no Hospital Universit\u00e1rio de Bras\u00edlia, DF, Brasil","volume":"80","author":"Name","year":"2005","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"Navin","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0275","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0280","unstructured":"NIH, 2004. Division of AIDS table for grading the severity of adults and pediatric adverse events: December 2004. http:\/\/www.ucdmc.ucdavis.edu?clinicaltrials\/documents\/DAIDS_AE_gradingTable_FinalDec2004.pdf (accessed May 25, 2009)."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0285","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1997.57.651","article-title":"A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)","volume":"57","author":"Oliveira-Neto","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0290","first-page":"496","article-title":"Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5mg\/kg\/day) and high dosage (20mg\/kg\/day) antimony regimens","volume":"45","author":"Oliveira-Neto","year":"1997","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-4362.1997.00188.x","article-title":"Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil\u2014an area of Leishmania (V.) braziliensis transmission","volume":"36","author":"Oliveira-Neto","year":"1997","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0300","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1590\/S0365-05962004000400008","article-title":"Paniculite eosinof\u00edlica localizada em conseq\u00fc\u00eancia de inje\u00e7\u00f5es intramusculares de composto de antim\u00f4nio pentavalente para o tratamento de leishmaniasis tegumentar americana","volume":"79","author":"Oliveira-Neto","year":"2004","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0305","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S0037-86822006000400001","article-title":"An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable","volume":"39","author":"Oliveira-Neto","year":"2006","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0310","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4269\/ajtmh.1985.34.856","article-title":"American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules","volume":"34","author":"Oster","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0315","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0320","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0037-86822001000100002","article-title":"Leishmaniose tegumentar na regi\u00e3o metropolitana de Belo Horizonte: aspectos cl\u00ednicos, laboratoriais, terap\u00eauticos e evolutivos (1989\u20131995)","volume":"34","author":"Passos","year":"2001","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0325","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S0100-879X1999000300008","article-title":"Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine","volume":"32","author":"Ribeiro","year":"1999","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.actatropica.2011.02.007_bib0330","first-page":"188","article-title":"Eficacia y tolerancia de la pentamidina en el tratamiento de la leishmaniasis cut\u00e1nea producida por Leishmania (V.) panamensis en Colombia","volume":"26","author":"Robledo","year":"2006","journal-title":"Biomedica"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0036-46651999000100007","article-title":"Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis","volume":"41","author":"Rodrigues","year":"1999","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0340","first-page":"58","article-title":"Simp\u00f3sio sobre Tratamento das Leishmanioses","volume":"34","author":"Romero","year":"2001","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0345","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of Cutaneous Leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V) guyanensis in Brazil: Therapeutics response to Meglumine Antimoniate","volume":"65","author":"Romero","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0350","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0074-02762003000100019","article-title":"High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls","volume":"98","author":"Romero","year":"2003","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0355","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/136485906X105561","article-title":"Comparison between one and two injections of pentamidine isethionate, at 7mg\/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana","volume":"100","author":"Roussel","year":"2006","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0360","first-page":"148","article-title":"Evaluacion de la efectividad y toxicidad del pentostam y del glucantime em el tratamiento de la leishmaniasis cut\u00e2nea","volume":"12","author":"S\u00e1enz","year":"1987","journal-title":"Rev. M\u00e9d. Panam\u00e1"},{"key":"10.1016\/j.actatropica.2011.02.007_bib0365","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"S\u00e1enz","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0370","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0037-86821999000400008","article-title":"Estudo comparativo entre estibogluconato de s\u00f3dio BP88\u00ae e antimoniato de meglumina no tratamento da leishmaniose cut\u00e2nea: efic\u00e1cia e seguran\u00e7a","volume":"32","author":"Saldanha","year":"1999","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0375","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0037-86822000000400009","article-title":"Estudo comparativo entre estibogluconato de s\u00f3dio BP 88\u00ae e antimoniato de meglumina no tratamento da leishmaniose cut\u00e2nea: toxidade bioqu\u00edmica e card\u00edaca","volume":"33","author":"Saldanha","year":"2000","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0380","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1067\/S0190-9622(03)01576-7","article-title":"Experience with New World cutaneous leishmaniasis in travelers","volume":"49","author":"Scope","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0385","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/qjmed\/92.11.659","article-title":"Out-patient parenteral antimicrobial therapy\u2014a viable option for the management of cutaneous leishmaniasis","volume":"92","author":"Seaton","year":"1999","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.actatropica.2011.02.007_bib0390","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2006.06.044","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis","volume":"56","author":"Solomon","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4269\/ajtmh.1994.50.107","article-title":"Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine","volume":"50","author":"Soto","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0400","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0405","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"Soto","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0410","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0415","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/clind\/16.3.417","article-title":"Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia","volume":"16","author":"Soto-Mancipe","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0420","first-page":"361","article-title":"Tratamento da leishmaniose tegumentar americana: resultados preliminares com a pentamidina","volume":"60","author":"Talhari","year":"1985","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0425","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-4632.2008.03417.x","article-title":"Treatment of New World cutaneous leishmaniasis\u2014a systematic review with a meta-analysis","volume":"47","author":"Tuon","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-126-3-199702010-00010","article-title":"Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial","volume":"126","author":"Velez","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0435","unstructured":"WHO, 2007. Report of the Consultative Meeting on Cutaneous Leishmaniasis. Geneva."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0440","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1086\/514689","article-title":"Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis","volume":"27","author":"Wortmann","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0445","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.02.007_bib0450","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1468-3083.1998.tb00950.x","article-title":"South American cutaneous leishmaniasis: report of ten cases in Israeli travelers","volume":"11","author":"Zlotogorski","year":"1998","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X11000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X11000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T03:10:41Z","timestamp":1686021041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X11000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0001706X11000325"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2011.02.007","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}